tiprankstipranks
Instil Bio (TIL)
NASDAQ:TIL
US Market

Instil Bio (TIL) Financial Statements

47 Followers

Instil Bio Financial Overview

Instil Bio's market cap is currently ―. The company's EPS TTM is $-18.961; its P/E ratio is -0.67; Instil Bio is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-2.98. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -22.32M$ -10.95M$ -65.43M$ -18.07M$ -58.45M
EBITDA$ -21.33M$ -9.91M$ -64.48M-$ -56.40M
Net Income Common Stockholders$ -24.30M$ -12.93M$ -67.43M$ -18.66M$ -57.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 153.78M$ 150.36M$ 183.45M$ 201.70M$ 223.19M
Total Assets$ 306.30M$ 325.63M$ 340.27M$ 408.31M$ 427.17M
Total Debt$ 84.13M$ 84.30M$ 84.46M$ 85.21M$ 81.25M
Net Debt$ -69.66M$ -66.05M$ -98.98M$ -116.48M$ -141.95M
Total Liabilities$ 100.48M$ 99.80M$ 106.25M$ 111.79M$ 116.02M
Stockholders Equity$ 205.83M$ 225.83M$ 234.02M$ 296.52M$ 311.15M
Cash Flow-
Free Cash Flow$ -14.39M$ -13.44M$ -19.58M-$ -42.89M
Operating Cash Flow$ -14.39M$ -13.38M$ -14.43M$ -19.56M$ -34.43M
Investing Cash Flow$ 9.24M$ 13.95M$ 2.32M$ 10.33M$ 14.29M
Financing Cash Flow--$ -587.00K$ 4.20M$ 4.47M
Currency in USD

Instil Bio Earnings and Revenue History

Instil Bio Debt to Assets

Instil Bio Cash Flow

Instil Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis